Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Miller

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical TrialsRoy F Chemaly, Sunwen Chou, Hermann Einsele, et al.
Hepatology (Baltimore, Md.)|March 24, 2025
Erratum: HDV RNA assays: Performance characteristics, clinical utility, and challengesHeiner Wedemeyer, Mitchell Leus, Thomas R Battersby, et al.
Hepatology (Baltimore, Md.)|August 28, 2023
HDV RNA assays: Performance characteristics, clinical utility, and challengesHeiner Wedemeyer, Mitchell Leus, Thomas R Battersby, et al.
Alimentary Pharmacology & Therapeutics|October 25, 2023
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver ForumMelissa Palmer, David E Kleiner, Zachary Goodman, et al.
Open Forum Infectious Diseases|July 10, 2024
Long-acting HIV Treatments: Study Design, Logistics, and AccessNicholas A Murdock, Nayri E Alajaji, Robin Schaefer, et al.
Hepatology (Baltimore, Md.)|October 24, 2017
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory scienceMohammad Shadab Siddiqui, Stephen A Harrison, Manal F Abdelmalek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2023
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug ClassesMarion G Peters, Man-Fung Yuen, Norah Terrault, et al.
Journal of Virus Eradication|March 13, 2023
Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South AfricaNombuyiselo Mofokeng, Tongai G Maponga, Marije van Schalkwyk, et al.
Nature Reviews. Gastroenterology & Hepatology|January 30, 2026
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver diseaseJeffrey V Lazarus, Christopher J Kopka, Aina Nicolàs, et al.
BMC Infectious Diseases|November 17, 2017
The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testingJoseph D Tucker, Kathrine Meyers, John Best, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 24, 2018
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical TrialsRoy F Chemaly, Sunwen Chou, Hermann Einsele, et al.
Hepatology (Baltimore, Md.)|March 24, 2025
Erratum: HDV RNA assays: Performance characteristics, clinical utility, and challengesHeiner Wedemeyer, Mitchell Leus, Thomas R Battersby, et al.
Hepatology (Baltimore, Md.)|August 28, 2023
HDV RNA assays: Performance characteristics, clinical utility, and challengesHeiner Wedemeyer, Mitchell Leus, Thomas R Battersby, et al.
Alimentary Pharmacology & Therapeutics|October 25, 2023
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver ForumMelissa Palmer, David E Kleiner, Zachary Goodman, et al.
Open Forum Infectious Diseases|July 10, 2024
Long-acting HIV Treatments: Study Design, Logistics, and AccessNicholas A Murdock, Nayri E Alajaji, Robin Schaefer, et al.
Hepatology (Baltimore, Md.)|October 24, 2017
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory scienceMohammad Shadab Siddiqui, Stephen A Harrison, Manal F Abdelmalek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 2023
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug ClassesMarion G Peters, Man-Fung Yuen, Norah Terrault, et al.
Journal of Virus Eradication|March 13, 2023
Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South AfricaNombuyiselo Mofokeng, Tongai G Maponga, Marije van Schalkwyk, et al.
Nature Reviews. Gastroenterology & Hepatology|January 30, 2026
Lessons learned from viral hepatitis testing that inform law and policy responses to steatotic liver diseaseJeffrey V Lazarus, Christopher J Kopka, Aina Nicolàs, et al.
BMC Infectious Diseases|November 17, 2017
The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testingJoseph D Tucker, Kathrine Meyers, John Best, et al.
Pageof 11